Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tokyo CRO, Inc. is a Japanese contract research organization (CRO) that provides comprehensive clinical development and pharmaceutical affairs consulting services. Founded in 2003 as a spin-off from the Tokyo Research Center of Clinical Pharmacology, the company established a strong presence in Japan, China, and South Korea, offering full-service support for clinical trials, including monitoring, data management, and regulatory affairs. In 2010, Tokyo CRO was acquired by JGC Corporation and later integrated into EPS Corporation (now EPS Holdings) in 2014. Its operations now form part of the EPS Group, one of Japan's largest CRO networks, continuing to support global biopharmaceutical companies in the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tokyo CRO.